News about "XFG Variant"

FDA Approves Pfizer-BioNTech's XFG-Targeted COVID-19 Vaccine for 2026-27 Season

FDA Approves Pfizer-BioNTech's XFG-Targeted COVID-19 Vaccine for 2026-27 Season

Pfizer and BioNTech’s updated Comirnaty XFG vaccine is set to begin shipping across the US following FDA approval for the 2026–27 COVID-19 season.

XFG Variant | 31/08/2026 | By News Bureau

European Commission Approves Pfizer-BioNTech's XFG-Adapted COVID-19 Vaccine for 2026-27 Season

European Commission Approves Pfizer-BioNTech's XFG-Adapted COVID-19 Vaccine for 2026-27 Season

The European Commission has approved Pfizer and BioNTech's monovalent XFG-adapted COVID-19 vaccine for the 2026–27 vaccination season that authorised for people aged six months and above, is designed to enhance protection against currently circulating SARS-CoV-2 variants and will be supplied across the European Union and selected European countries.

XFG Variant | 31/07/2026 | By News Bureau

EMA Recommends XFG-Targeted COVID-19 Vaccines for 2026-2027 Immunisation Campaign

EMA Recommends XFG-Targeted COVID-19 Vaccines for 2026-2027 Immunisation Campaign

The European Medicines Agency’s Emergency Task Force has recommended updating COVID-19 vaccines to target the XFG variant for the 2026–2027 vaccination season, aiming to enhance protection against circulating SARS-CoV-2 strains.

XFG Variant | 01/06/2026 | By News Bureau 219


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members